Daily Stock Analysis, ATRC, AtriCure Inc, priceseries

AtriCure Inc. Daily Stock Analysis
Stock Information
Open
18.59
Close
18.93
High
19.04
Low
18.59
Previous Close
18.57
Daily Price Gain
0.36
YTD High
19.79
YTD High Date
Jan 3, 2017
YTD Low
14.78
YTD Low Date
Jan 23, 2017
YTD Price Change
-0.27
YTD Gain
-1.41%
52 Week High
20.40
52 Week High Date
Nov 15, 2016
52 Week Low
13.44
52 Week Low Date
May 12, 2016
52 Week Price Change
2.64
52 Week Gain
16.21%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 9. 2015
18.41
Mar 31. 2015
20.46
16 Trading Days
11.14%
Link
LONG
Nov 7. 2016
17.50
Nov 17. 2016
18.59
8 Trading Days
6.24%
Link
Company Information
Stock Symbol
ATRC
Exchange
NasdaqGM
Company URL
http://www.atricure.com
Company Phone
513-755-4100
CEO
Michael H. Carrel
Headquarters
Ohio
Business Address
7555 INNOVATION WAY, MASON, OH 45040
Sector
separate tissues to provide access to anatomical structures that are targeted for ablation; and Estech cardiac surgery instruments that are used during surgical procedures for repair or replacement of certain heart valves. The company sells its products through independent distributors and direct sales personnel. AtriCure, Inc. is headquartered in Mason, Ohio.
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0001323885
About

AtriCure, Inc., a medical device company, provides atrial fibrillation solutions to hospitals and medical centers in the United States and internationally.

Description

AtriCure, Inc., a medical device company, provides atrial fibrillation solutions to hospitals and medical centers in the United States and internationally. The company offers Isolator Synergy System and related radio frequency(RF) ablation devices, which include clamps that are used for ablation during open-heart procedures; ablation and sensing unit, a compact power generator that delivers bipolar RF energy to its clamps, multifunctional pens, and Coolrail linear ablation devices; AtriCure Switch Box, a compact switch box, which offers the technology needed for the dual pulsing electrodes in clamps; and Coolrail linear ablation device, a disposable linear RF ablation device that allows physicians to create an expanded cardiac ablation lesion set during minimally invasive procedures. It also provides Isolator multifunctional pens that enable surgeons to evaluate cardiac arrhythmias; perform temporary cardiac pacing, sensing, and stimulation; and ablate cardiac tissue with the same device. In addition, the company provides COBRA Fusion Surgical Ablation System and EPi-Sense Guided Coagulation System; electrosurgical unit, a compact power generator for use with Fusion ablation products; AFfirm Bipolar Pacing Probe is used to test lesions created in surgically treating the patient's arrhythmia; cryoICE cryoablation system used to ablate cardiac tissue for the treatment of cardiac arrhythmias; AtriClip system that is designed for the left atrial appendage management; nContact RF generator; and Cannula, an access device and conduit for the ablation device. Further, it sells Lumitip dissector to separate tissues to provide access to anatomical structures that are targeted for ablation; and Estech cardiac surgery instruments that are used during surgical procedures for repair or replacement of certain heart valves. The company sells its products through independent distributors and direct sales personnel. AtriCure, Inc. is headquartered in Mason, Ohio.